Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida II. Biological properties

Journal of Antibiotics

Volumn 49, Issue 3, 1996, Pages 263-266

  Lampis, Giorgio ^a   Deidda, Delia ^a   Maullu, Carlo ^a   Petruzzelli, Sabrina ^a   Pompei, Raffaello ^a   Delle Monache, Franco ^b   Satta, Giuseppe ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; KARALICIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SPECIFICITY; DRUG STRUCTURE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; YEAST;

ANIMALS; ANISOLES; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; CANDIDA; CELL DEATH; CELL LINE; CERCOPITHECUS AETHIOPS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; MOLECULAR STRUCTURE; PENTANOLS; POLIOVIRUS; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; VACCINIA VIRUS; VERO CELLS; YEASTS;

EID: 0029874652     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.263     Document Type: Article

References (11)

1. LAMPIS, G.; D. DEIDDA, C. MAULLU, M. A. MADEDDU, R. POMPEI, F. D. MONACHE & G. SATTA: Sattabacins and sattazolins: new biologically active compounds with antiviral properties extracted from a Bacillus sp. J. Antibiotics 48: 707-712, 1995
2. LAMPIS, G.; D. DEIDDA, C. MAULLU, S. PETRUZZELLI, R. POMPEI, F. D. MONACHE & G. SATTA: Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. I. Production, isolation, physico-chemical properties and structure elucidation. J. Antibiotics 49: 260-262, 1996
3. GERALD, L. G.: Pseudomonas. Ed., E. H. LENNETTE et al., 4th edn., pp. 526-541, American Society for Microbiology, Washington, D.C., 1985
4. AMSTERDAM, D.: Susceptibility testing of antibiotics in liquid media. In Antibiotics in Laboratory Medicine. Ed., LORIAN V., 3rd edn., pp. 53-105, Williams and Wilkins, Baltimore, 1991
5. MCGINNIS, M. R. & M. G. RINALDI: Antifungal drugs: mechanism of action, drug resistance, susceptibility testing, and assay of activity in biological fluids. In Antibiotics in Laboratory Medicine. Ed., LORIAN V., 3rd edn., pp. 198-257, Williams and Wilkins, Baltimore, 1991
6. HOWELL, C. R. & R. D. STIPANOVIC: Suppression of Pythium ultimum induced damping-off of cotton seedlings by Pseudomonas fluorescens and its antibiotic, pyoluteorin. Phytopathology 70: 712-715, 1980
7. HOWELL, C. R.: Control of Rhizoctonia solari in cotton seedlings with Pseudomonas fluorescens and with an antibiotic produced by the bacterium. Phytopathology 69: 480-482, 1979
8. NOWAK-THOMPSON, B.; S. J. GOULD, J. KRAUS & J. E. LOPER: Production of 2,4-diacetylphloroglucinol by the biocontrol agent Pseudomonas fluorescens Pf-5. Can. J. Microbiol. 40: 1064-1066, 1994
9. KRAUS, J. & J. E. LOPER: Lack of evidence for a role of antifungal metabolite production by Pseudomonas fluorescens Pf-5 in biological control of Pythium damping-off of cucumber. Phytopathology 82: 264-271, 1992
10. MOSS, B. & R. FILLER: Irreversible effects of cycloheximide during the early period of vaccinia virus replication. J. Virol. 5: 99-108, 1970
11. WERTZ, G. W. & M. LEVINE: RNA synthesis by vesicular stomatitis virus and a small plaque mutant. Effects of cycloheximide. J. Virol. 12: 253-264, 1973